Singapore, May 10 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507)... Read More
Tokyo, May 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061485) titled 'Analysis of diet-gut microbiota correlation to prevent fatty deposits and fi... Read More
Tokyo, May 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061471) titled 'Safety Study on Excessive Intake of the Test Food - A Randomized, Placebo-Co... Read More
Tokyo, May 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061425) titled 'Single-Group Intervention Study on the Early Introduction of Multiple Nuts U... Read More
Tokyo, May 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060867) titled 'Retrospective observational study evaluating the clinical utility of liquid ... Read More
Tokyo, May 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061513) titled 'Fostering Healthy Preschool Initiatives in Myanmar: A School-Centred Multidi... Read More
Tokyo, May 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061512) titled 'Development and Efficacy Assessment of an Oral Health Education Program for ... Read More
Tokyo, May 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061509) titled 'Establishment of a Japanese essential oil and yuzu aromatherapy to improve h... Read More
Tokyo, May 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061508) titled 'Effects of foods containing medium-chain fatty acids on energy metabolic sta... Read More
Singapore, May 9 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy... Read More